$DD

DuPont de Nemours, Inc.

CIK:0001666700|SEC Filings

Consolidated Statements of Operations - USD ($) shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Income Statement [Abstract]
Net sales	$ 1,819	$ 1,749	$ 3,500	$ 3,361
Cost of sales	1,180	1,143	2,259	2,212
Research and development expenses	42	53	89	103
Selling, general and administrative expenses	269	262	524	496
Amortization of intangibles	68	74	136	149
Restructuring and asset related (benefits) charges – net	(3)	0	43	39
Acquisition, integration and separation costs	7	55	7	105
Equity in earnings (loss) of nonconsolidated affiliates	9	9	8	(6)
Sundry income (expense) – net	42	(9)	78	91
Interest expense	41	84	81	167
Income from continuing operations before income taxes	266	78	447	175
Provision for income taxes on continuing operations	75	54	106	71
Income from continuing operations, net of tax	191	24	341	104
(Loss) income from discontinued operations, net of tax	(44)	46	(30)	(615)
Net income (loss)	147	70	311	(511)
Net income attributable to noncontrolling interests	4	11	7	19
Net income (loss) available for DuPont common stockholders	$ 143	$ 59	$ 304	$ (530)
Per common share data:
Earnings per common share from continuing operations - basic (in usd per share)	$ 1.38	$ 0.17	$ 2.45	$ 0.73
(Loss) earnings per common share from discontinued operations - basic (in usd per share)	(0.32)	0.25	(0.22)	(4.53)
Earnings (loss) per common share - basic (in usd per share)	1.05	0.42	2.23	(3.80)
Earnings per common share from continuing operations - diluted (in usd per share)	1.37	0.17	2.43	0.73
(Loss) earnings per common share from discontinued operations - diluted (in usd per share)	(0.32)	0.25	(0.22)	(4.52)
Earnings (loss) per common share - diluted (in usd per share)	$ 1.05	$ 0.42	$ 2.22	$ (3.79)
Weighted-average common shares outstanding - basic (in shares)	135.9	139.6	136.3	139.6
Weighted-average common shares outstanding - diluted (in shares)	136.8	139.9	137.2	139.9

Consolidated Statements of Cash Flows - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Operating Activities
Net income (loss)	$ 311	$ (511)
Loss from discontinued operations	(30)	(615)
Net income from continuing operations	341	104
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	309	326
Credit for deferred income tax and other tax related items	45	9
(Earnings) losses of nonconsolidated affiliates (in excess of) less than dividends received	(6)	7
Net periodic pension benefit costs	6	2
Periodic benefit plan contributions	(28)	(23)
Restructuring and asset related charges – net	43	39
Interest rate swap gain	0	(51)
Stock based compensation	27	22
Donatelle contingent earn-out true-up	(14)	(12)
Other net (income) loss	(2)	16
Changes in assets and liabilities, net of effects of acquired and divested companies:
Accounts and notes receivable	(88)	(213)
Inventories	(29)	(51)
Accounts payable	92	(19)
Other assets and liabilities, net	(64)	(5)
Cash provided by operating activities – continuing operations	632	151
Investing Activities
Capital expenditures	(178)	(172)
Proceeds and adjustments to proceeds from sales of businesses, net of cash divested	1,158	0
Other investing activities, net	9	7
Cash provided by (used for) investing activities – continuing operations	989	(165)
Financing Activities
Changes in short-term borrowings	(60)	0
Purchases of common stock and forward contracts	(275)	0
Proceeds from issuance of Company stock	107	4
Employee taxes paid for share-based payment arrangements	(22)	(22)
Distributions to noncontrolling interests	(11)	(5)
Dividends paid to stockholders	(163)	(343)
Other financing activities, net	(1)	(7)
Cash used for financing activities – continuing operations	(425)	(373)
Cash Flows from Discontinued Operations
Cash (used for) provided by operating activities – discontinued operations	(158)	540
Cash used for investing activities – discontinued operations	(6)	(193)
Cash used for financing activities – discontinued operations	(3)	(17)
Cash (used for) provided by discontinued operations	(167)	330
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(7)	44
Increase (decrease) in cash, cash equivalents and restricted cash	1,022	(13)
Cash, cash equivalents and restricted cash from continuing operations, beginning of period	757	1,834
Cash, cash equivalents and restricted cash from discontinued operations, beginning of period	3	58
Cash, cash equivalents and restricted cash at beginning of period	760	1,892
Cash, cash equivalents and restricted cash from continuing operations, end of period	1,782	1,817
Cash, cash equivalents and restricted cash from discontinued operations, end of period	0	62
Cash, cash equivalents and restricted cash at end of period	$ 1,782	$ 1,879

Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Jun. 30, 2026	Dec. 31, 2025
Current Assets
Cash and cash equivalents	$ 1,740	$ 715
Restricted cash and cash equivalents	42	42
Accounts and notes receivable – net	1,751	1,669
Inventories	1,210	1,172
Prepaid and other current assets	113	121
Assets of discontinued operations	0	1,856
Total current assets	4,856	5,575
Property, plant and equipment – net of accumulated depreciation (June 30, 2026 - $3,694; December 31, 2025 - $3,565)	3,379	3,464
Other Assets
Goodwill	7,840	7,915
Other intangible assets	2,789	2,936
Investments and noncurrent receivables	981	432
Deferred income tax assets	221	282
Deferred charges and other assets	995	971
Total other assets	12,826	12,536
Total Assets	21,061	21,575
Current Liabilities
Short-term borrowings	0	60
Accounts payable	978	995
Income taxes payable	53	54
Accrued and other current liabilities	970	882
Liabilities of discontinued operations	0	314
Total current liabilities	2,001	2,305
Long-Term Debt	3,125	3,134
Other Noncurrent Liabilities
Deferred income tax liabilities	295	405
Pension and other post-employment benefits – noncurrent	400	432
Other noncurrent obligations	1,359	1,196
Total other noncurrent liabilities	2,054	2,033
Total Liabilities	7,180	7,472
Commitments and contingent liabilities
Stockholders' Equity
Common stock (authorized 555,555,556 shares of $0.01 par value each; issued 2026: 135,038,855 shares; 2025: 136,398,482 shares)	1	1
Additional paid-in capital	38,710	38,721
Accumulated deficit	(24,326)	(24,278)
Accumulated other comprehensive loss	(616)	(525)
Total DuPont stockholders' equity	13,769	13,919
Noncontrolling interests	112	184
Total equity	13,881	14,103
Total Liabilities and Equity	$ 21,061	$ 21,575